Back to Agenda
Payer Town Hall Meeting: WHO Fair Pricing
Session Chair(s)
Ad Schuurman, MBA, MSc
Head of the Business Contact Centre & International Affairs
National Health Care Institute (ZIN), Netherlands
Discussions in health care are moving from innovation and science to economics and affordability. Due to current developments in technology (many new, effective products), combined with high prices demanded by companies, the sustainability of health care systems is threatened. Expensive treatments for some patients displace effective treatments for other patients: the concept of solidarity, on which our health care systems are build, is disappearing. In this session we will explore the possibility of Fair Pricing by turning the process upside down: Can society decide the price for the products, treatments and healthcare they want access to? If so, can manufacturers deliver these products at a price the health care system is willing and able to pay?
Speaker(s)
Panel Discussion
Andrew Rintoul
WHO, Switzerland
Innovation, Access and Use
Panel Discussion
Anna Bucsics, DrMed, MD
MoCA, Austria
Project Advisor
Panel Discussion
Alexander Natz, JD
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Secretary General
Panel Discussion
Simone Boselli, MA
EURORDIS, Belgium
Public Affairs Director
Have an account?